You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Study finds primary-care doctors often overlook prostate cancer risk in Black men
- 2. Development and validation of a prostate cancer risk prediction model for the elevated PSA population
- 3. The predictive value of PSMA PET/CT in determining pathological upgrading of prostate cancer: A pooling up analysis
- 4. New hurdle seen to prostate screening: primary-care docs
- 5. SEPTEMBER IS PROSTATE CANCER AWARENESS MONTH: PROCURE PROTON THERAPY CENTER ENCOURAGES MEN TO LEARN ABOUT THEIR OPTIONS
- 6. Orthocell's Remplir used in nerve-sparing prostate cancer surgery
- 7. Globally Significant Opportunity Emerges as Remplir™ is used in Nerve-Sparing Prostate Cancer Surgery
- 8. Machine learning-based analysis identifies glucose metabolism-related genes ADPGK as potential diagnostic biomarkers for clear cell renal cell carcinoma
- 9. The paradoxical role of stem cells in osteosarcoma: from pathogenesis to therapeutic breakthroughs
- 10. ‘I was told I had two weeks to live' – why are so many young, fit, non-smoking women getting lung cancer?
Last updated at 12:19 GMT
Hot News Makers
Health/Pharma Companies
-
66354.97
-
19175.02
-
13374.15
-
12794.34
-
11195.05
-
9770.22
-
9529.51
-
8802.10
-
8631.35
-
7156.13
Drugs, Treatments, Trials
-
25347.68
-
11611.51
-
6856.68
-
5635.70
-
3682.62
-
3435.94
-
3268.93
-
1848.79
-
1720.13
-
1604.91
Last updated at 12:10 GMT
